These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34330186)

  • 21. Simple animal models for amyotrophic lateral sclerosis drug discovery.
    Patten SA; Parker JA; Wen XY; Drapeau P
    Expert Opin Drug Discov; 2016 Aug; 11(8):797-804. PubMed ID: 27249162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
    Choi SH; Kim YH; Quinti L; Tanzi RE; Kim DY
    Mol Neurodegener; 2016 Dec; 11(1):75. PubMed ID: 27938410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a novel small molecule PT109 with multi-targeted effects against Alzheimer's disease in vitro and in vivo.
    Chen Q; Tu Y; Mak S; Chen J; Lu J; Chen C; Yang X; Wang S; Wen S; Ma S; Li M; Han Y; Wah-Keung Tsim K; Pi R
    Eur J Pharmacol; 2020 Sep; 883():173361. PubMed ID: 32673674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Ju Y; Chakravarty H; Tam KY
    ACS Chem Neurosci; 2020 Oct; 11(20):3346-3357. PubMed ID: 33001625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes.
    Sharman MJ; Moussavi Nik SH; Chen MM; Ong D; Wijaya L; Laws SM; Taddei K; Newman M; Lardelli M; Martins RN; Verdile G
    PLoS One; 2013; 8(6):e66235. PubMed ID: 23805206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approaches to models of Alzheimer's disease pathology for drug screening and development.
    Shaughnessy L; Chamblin B; McMahon L; Nair A; Thomas MB; Wakefield J; Koentgen F; Ramabhadran R
    J Mol Neurosci; 2004; 24(1):23-32. PubMed ID: 15314246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease.
    Li C; Ebrahimi A; Schluesener H
    Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor.
    Pu YZ; Liang L; Fu AL; Liu Y; Sun L; Li Q; Wu D; Sun MJ; Zhang YG; Zhao BQ
    Curr Alzheimer Res; 2017; 14(6):668-679. PubMed ID: 27978793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
    Tweedie D; Ferguson RA; Fishman K; Frankola KA; Van Praag H; Holloway HW; Luo W; Li Y; Caracciolo L; Russo I; Barlati S; Ray B; Lahiri DK; Bosetti F; Greig NH; Rosi S
    J Neuroinflammation; 2012 May; 9():106. PubMed ID: 22642825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster.
    Sandin L; Bergkvist L; Nath S; Kielkopf C; Janefjord C; Helmfors L; Zetterberg H; Blennow K; Li H; Nilsberth C; Garner B; Brorsson AC; Kågedal K
    FEBS J; 2016 Oct; 283(19):3508-3522. PubMed ID: 27562772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The GSK3β inhibitor, TDZD-8, rescues cognition in a zebrafish model of okadaic acid-induced Alzheimer's disease.
    Koehler D; Shah ZA; Williams FE
    Neurochem Int; 2019 Jan; 122():31-37. PubMed ID: 30392874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural non-trasgenic animal models for research in Alzheimer's disease.
    Sarasa M; Pesini P
    Curr Alzheimer Res; 2009 Apr; 6(2):171-8. PubMed ID: 19355852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.
    Bergkvist L; Du Z; Elovsson G; Appelqvist H; Itzhaki LS; Kumita JR; Kågedal K; Brorsson AC
    FEBS Open Bio; 2020 Mar; 10(3):338-350. PubMed ID: 31823504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's Disease, Drosophila melanogaster and Polyphenols.
    Jimenez-Del-Rio M; Velez-Pardo C
    Adv Exp Med Biol; 2015; 863():21-53. PubMed ID: 26092625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics.
    Paul D; Chipurupalli S; Justin A; Raja K; Mohankumar SK
    J Pharmacol Toxicol Methods; 2020; 106():106932. PubMed ID: 33091537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.
    Cacabelos R
    Mol Diagn Ther; 2007; 11(6):385-405. PubMed ID: 18078356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.